Evidence map›Paper›PMID 38589581›Full record

ArticleScientific reports2024

The laboratory parameters-derived CoLab score as an indicator of the host response in ICU COVID-19 patients decreases over time: a prospective cohort study.

Tom Schoenmakers, Mathie P G Leers, Stefan H M Gorissen, Inge H M van Loo, Frank van Rosmalen, Eda Aydeniz, Joep Schellens, Marielle Driessen, Ruben Deneer, Wilhelmine P H G Verboeket-van de Venne and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tom SchoenmakersDepartment of Clinical Chemistry and Hematology, Zuyderland Medical Center, Sittard-Geleen, Dr. H. Van Der Hoffplein 1, 6162 BG, Sittard-Geleen, The Netherlands. t.schoenmakers@zuyderland.nl.ORCID 0000-0002-1576-7832
Mathie P G LeersDepartment of Clinical Chemistry and Hematology, Zuyderland Medical Center, Sittard-Geleen, Dr. H. Van Der Hoffplein 1, 6162 BG, Sittard-Geleen, The Netherlands.ORCID 0000-0001-5186-5600
Stefan H M GorissenZuyderland Academy, Zuyderland Medical Center, Sittard-Geleen/Heerlen, The Netherlands.ORCID 0000-0003-3737-9053
Inge H M van LooDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, Maastricht University Medical Center +, Maastricht, The Netherlands.ORCID 0000-0002-5960-4357
Frank van RosmalenDepartment of Intensive Care Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands.ORCID 0000-0002-9522-3711
Eda AydenizDepartment of Intensive Care Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands.
Joep SchellensDepartment of Intensive Care Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands.
Marielle DriessenDepartment of Intensive Care Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands.
Ruben DeneerDepartment of Clinical Chemistry and Hematology, Zuyderland Medical Center, Sittard-Geleen, Dr. H. Van Der Hoffplein 1, 6162 BG, Sittard-Geleen, The Netherlands.
Wilhelmine P H G Verboeket-van de VenneDepartment of Clinical Chemistry and Hematology, Zuyderland Medical Center, Sittard-Geleen, Dr. H. Van Der Hoffplein 1, 6162 BG, Sittard-Geleen, The Netherlands.ORCID 0000-0003-4980-0116
Petra F G WolffsDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, Maastricht University Medical Center +, Maastricht, The Netherlands.ORCID 0000-0002-5326-3985
Walther N K A van MookDepartment of Intensive Care Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands.ORCID 0000-0003-2398-8878
Bas C T van BusselDepartment of Intensive Care Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands.ORCID 0000-0003-1621-7848
CoLaIC-consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CoLab score was developed and externally validated to rule out COVID-19 among suspected patients presenting at the emergency department. We hypothesized a within-patient decrease in the CoLab score over time in an intensive care unit (ICU) cohort. Such a decrease would create the opportunity to potentially rule out the need for isolation when the infection is overcome. Using linear mixed-effects models, data from the Maastricht Intensive Care COVID (MaastrICCht) cohort were used to investigate the association between time and the CoLab score. Models were adjusted for sex, APACHE II score, ICU mortality, and daily SOFA score. The CoLab score decreased by 0.30 points per day (95% CI - 0.33 to - 0.27), independent of sex, APACHE II, and Mortality. With increasing SOFA score over time, the CoLab score decreased more strongly (- 0.01 (95% CI - 0.01 to - 0.01) additional decrease per one-point increase in SOFA score.) The CoLab score decreased in ICU patients on mechanical ventilation for COVID-19, with a one-point reduction per three days, independent of sex, APACHE II, and ICU mortality, and somewhat stronger with increasing multi-organ failure over time. This suggests that the CoLab score would decrease below a threshold where COVID-19 can be excluded.

Indexed as

COVID-19APACHECritical CareHumansIntensive Care UnitsPrognosisProspective StudiesRetrospective StudiesCoLab scoreCOVID-19Linear mixed-effects modelsSARS-CoV-2

Identifiers

PMID38589581
PMCPMC11001996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.